Angiotensin II regulates NOS expression in afferent arterioles of the developing porcine kidney.
NO protection is crucial against angiotensin II (ANG II) mediated vasoconstriction in postnatal preglomerular resistance vessels. Although whole kidney NOS is developmentally regulated, NOS regulation in developing renal resistance vessels is unknown. The hypothesis was NOS expression and function in developing afferent arterioles are regulated by ANG II through AT1 and AT2 receptors. Afferent arterioles from porcine kidneys, ages newborn, 7, 21 d, and adult, were dissected using a polybead perfusion technique. Dissected afferent arterioles were treated with ANG II and with either the AT1 receptor inhibitor candesartan or the AT2 receptor inhibitor PD 123319 and evaluated for NOS isoform expression and NOS enzymatic activity. Although NOS activity and neuronal NOS (nNOS) expression were greater in the newborn than in the adult, endothelial NOS (eNOS) expression was greater in the adult. ANG II increased NOS activity and eNOS expression at all ages, but nNOS expression only in developing afferents. AT1 and AT2 receptor blockade significantly attenuated NOS activity and eNOS expression at all ages, but nNOS expression only in developing afferents. ANG II regulates nNOS and eNOS expression and NOS activity in afferent arterioles of the developing kidney via AT1 and AT2 receptors.
Ratliff
Brian B
BB
Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23501, USA. ratlifbb@gmail.com
Sekulic
Miroslav
M
Rodebaugh
Justin
J
Solhaug
Michael J
MJ
D000328:Adult; D000804:Angiotensin II / Q000378:metabolism*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000378:metabolism; D057912:Angiotensin II Type 2 Receptor Blockers; D000818:Animals; D001160:Arterioles / Q000166:cytology / Q000196:embryology / Q000378:metabolism*; D006439:Hemodynamics; D006801:Humans; D007231:Infant, Newborn; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism*; D007668:Kidney / Q000098:blood supply / Q000196:embryology / Q000201:enzymology; D009569:Nitric Oxide / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I / Q000235:genetics / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000235:genetics / Q000378:metabolism*; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000378:metabolism; D034421:Sus scrofa
D047228:Angiotensin II Type 1 Receptor Blockers; D057912:Angiotensin II Type 2 Receptor Blockers; D007527:Isoenzymes; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II; D009569:Nitric Oxide; D052248:Nitric Oxide Synthase Type I; D052250:Nitric Oxide Synthase Type III
Hypertension. 2000 Jan;35(1 Pt 2):337-41
10642321
Am J Physiol. 1980 May;238(5):R432-7
6246818
J Biol Chem. 2001 May 25;276(21):17625-8
11292821
Am J Physiol. 1995 May;268(5 Pt 2):F885-98
7539586
Anat Rec. 1979 Jun;194(2):187-99
464322
Pediatr Nephrol. 2009 Feb;24(2):355-65
18836750
Dev Pharmacol Ther. 1980;1(4):217-28
7002510
Pediatr Res. 1996 Mar;39(3):527-33
8929876
FASEB J. 2001 Sep;15(11):1909-20
11532971
J Am Soc Nephrol. 2001 Jun;12(6):1122-1127
11373335
Am J Physiol. 1994 Sep;267(3 Pt 2):F497-503
8092264
J Clin Invest. 1992 Aug;90(2):659-65
1379616
Physiol Res. 1996;45(4):323-8
9085357
Am J Physiol. 1995 Jun;268(6 Pt 2):F1164-76
7541956
Biol Neonate. 1996;69(6):389-98
8862465
Am J Physiol. 1988 Apr;254(4 Pt 2):F582-7
3281475
Hypertension. 1998 Jan;31(1 Pt 2):283-8
9453317
Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):162-74
17164144
Pediatr Nephrol. 2007 Aug;22(8):1135-42
17437130
Pediatr Res. 1996 Aug;40(2):192-7
8827766
Am J Physiol. 1993 Aug;265(2 Pt 2):F264-71
8368335
J Clin Invest. 1991 May;87(5):1656-63
2022735
Am J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1512-20
11959695
J Physiol. 1972 Jun;223(2):395-409
5039280
Pediatr Nephrol. 2001 Nov;16(11):868-73
11685591
Clin Perinatol. 1981 Jun;8(2):347-59
7023790
Am J Physiol Regul Integr Comp Physiol. 2000 Jun;278(6):R1453-9
10848511
Eur J Pharmacol. 2005 Nov 21;525(1-3):112-6
16256981
FASEB J. 1998 Jul;12(10):773-90
9657518
Am J Physiol. 1971 Nov;221(5):1431-5
5124288
Pediatr Res. 1971 Aug;5(8):335-44
5146081
Pediatr Res. 1993 Dec;34(6):750-4
8108187
Am J Physiol Renal Physiol. 2001 Jun;280(6):F996-F1000
11352839
Am J Physiol Regul Integr Comp Physiol. 2001 May;280(5):R1269-75
11294743
J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S220-4
9892167
Pflugers Arch. 2007 Jan;453(4):477-86
17051392
Kidney Int. 2004 Nov;66(5):1949-58
15496166
Pediatr Res. 1970 Jan;4(1):7-13
5417002
Acta Physiol Scand. 1977 Mar;99(3):261-9
848303